NPTX2 and cognitive dysfunction in Alzheimer’s Disease

Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. Here, we present findings supporting a special role for excitatory synapses connecting pyramidal neurons of the hippocampus and cortex with fast-spiking parvalbumin (PV) interneurons that control network excitability and rhythmicity. Excitatory synapses on PV interneurons are dependent on the AMPA receptor subunit GluA4, which is regulated by presynaptic expression of the synaptogenic immediate early gene NPTX2 by pyramidal neurons. In a mouse model of AD amyloidosis, Nptx2-/- results in reduced GluA4 expression, disrupted rhythmicity, and increased pyramidal neuron excitability. Postmortem human AD cortex shows profound reductions of NPTX2 and coordinate reductions of GluA4. NPTX2 in human CSF is reduced in subjects with AD and shows robust correlations with cognitive performance and hippocampal volume. These findings implicate failure of adaptive control of pyramidal neuron-PV circuits as a pathophysiological mechanism contributing to cognitive failure in AD. DOI: http://dx.doi.org/10.7554/eLife.23798.001

[1]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[2]  Arthur L. Benton,et al.  Word fluency and brain damage , 1967 .

[3]  Benjamin J. Shannon,et al.  Coherent spontaneous activity identifies a hippocampal-parietal memory network. , 2006, Journal of neurophysiology.

[4]  W. Singer,et al.  Dynamic predictions: Oscillations and synchrony in top–down processing , 2001, Nature Reviews Neuroscience.

[5]  T. Comery,et al.  Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[6]  Ira Driscoll,et al.  Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly , 2006, Annals of neurology.

[7]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[8]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[9]  P. Worley,et al.  Pentraxins Coordinate Excitatory Synapse Maturation and Circuit Integration of Parvalbumin Interneurons , 2015, Neuron.

[10]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[11]  B. Sakmann,et al.  Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS , 1995, Neuron.

[12]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[13]  M. Hutton,et al.  Oral Treatment with a γ-Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer's Disease , 2010, Journal of Pharmacology and Experimental Therapeutics.

[14]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[15]  Michael W. Weiner,et al.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2015, Alzheimer's & Dementia.

[16]  A. Dale,et al.  CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease , 2010, The Journal of Neuroscience.

[17]  R. Huganir,et al.  Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent β-Amyloid Generation , 2011, Cell.

[18]  Charles D. Smith,et al.  Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment , 2009, Neuroscience Letters.

[19]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[20]  Kevin P. Jensen,et al.  Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern , 2010, Nucleic Acids Res..

[21]  H. Nelson.  A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.

[22]  Stuart L. Johnson,et al.  miR-96 regulates the progression of differentiation in mammalian cochlear inner and outer hair cells , 2011, Proceedings of the National Academy of Sciences.

[23]  D. Wechsler.  A Standardized Memory Scale for Clinical Use , 1945 .

[24]  S. Resnick,et al.  Longitudinal brain activity changes in asymptomatic Alzheimer disease , 2012, Brain and behavior.

[25]  G. Turrigiano.  Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. , 2012, Cold Spring Harbor perspectives in biology.

[26]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[27]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[28]  Fiona E. N. LeBeau,et al.  Recruitment of Parvalbumin-Positive Interneurons Determines Hippocampal Function and Associated Behavior , 2007, Neuron.

[29]  Ying Chang,et al.  Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. , 2013, Oncology reports.

[30]  N Butters,et al.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. , 1992, Archives of neurology.

[31]  G. Buzsáki,et al.  Mechanisms of gamma oscillations. , 2012, Annual review of neuroscience.

[32]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[33]  T. Comery,et al.  Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[35]  T. Südhof,et al.  Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses , 2017, The Journal of Neuroscience.

[36]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[37]  I. Lott,et al.  Alzheimer's disease in Down syndrome: neurobiology and risk. , 2007, Mental retardation and developmental disabilities research reviews.

[38]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[39]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[40]  D. Delis,et al.  The California verbal learning test , 2016 .

[41]  M. C. Angulo,et al.  Subunit Composition, Kinetic, and Permeation Properties of AMPA Receptors in Single Neocortical Nonpyramidal Cells , 1997, The Journal of Neuroscience.

[42]  O. Steward,et al.  Synaptic Clustering of AMPA Receptors by the Extracellular Immediate-Early Gene Product Narp , 1999, Neuron.

[43]  J. Csicsvari,et al.  Oscillatory Coupling of Hippocampal Pyramidal Cells and Interneurons in the Behaving Rat , 1999, The Journal of Neuroscience.

[44]  B. de Strooper,et al.  ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 , 2011, Proceedings of the National Academy of Sciences.

[45]  Jing Wu,et al.  Arc/Arg3.1 Mediates Homeostatic Synaptic Scaling of AMPA Receptors , 2006, Neuron.

[46]  I. Driscoll,et al.  Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? , 2011, Current Alzheimer research.

[47]  Bruce L. McNaughton,et al.  Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles , 1999, Nature Neuroscience.

[48]  D. Borchelt,et al.  Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.

[49]  M. Hou,et al.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.

[50]  D. Wechsler.  WAIS-R manual : Wechsler adult intelligence scale-revised , 1981 .

[51]  Steffen B. E. Wolff,et al.  mGluR1/5-Dependent Long-Term Depression Requires the Regulated Ectodomain Cleavage of Neuronal Pentraxin NPR by TACE , 2008, Neuron.

[52]  R. Dahiya,et al.  MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer , 2013, PloS one.

[53]  Sebastien Ourselin,et al.  Functional connectivity in autosomal dominant and late-onset Alzheimer disease. , 2014, JAMA neurology.

[54]  Y. Gong,et al.  Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers , 2012, Digestive Diseases and Sciences.

[55]  References , 1971 .

[56]  A. Vortmeyer,et al.  Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein , 2013, Neuron.

[57]  K. Deisseroth,et al.  Arc/Arg3.1 Is a Postsynaptic Mediator of Activity-Dependent Synapse Elimination in the Developing Cerebellum , 2013, Neuron.

[58]  N Butters,et al.  Episodic and semantic memory: a comparison of amnesic and demented patients. , 1987, Journal of clinical and experimental neuropsychology.

[59]  J. Brewer,et al.  Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimer Disease , 2009, American Journal of Neuroradiology.

[60]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[61]  Patrick M M Bossuyt,et al.  Reporting standards for studies of diagnostic test accuracy in dementia , 2014, Neurology.

[62]  E. Kaplan,et al.  The Boston naming test , 2001 .

[63]  Carol A Barnes,et al.  Experience-Dependent Coincident Expression of the Effector Immediate-Early Genes Arc and Homer 1a in Hippocampal and Neocortical Neuronal Networks , 2002, The Journal of Neuroscience.

[64]  R. O’Brien,et al.  Synaptically Targeted Narp Plays an Essential Role in the Aggregation of AMPA Receptors at Excitatory Synapses in Cultured Spinal Neurons , 2002, The Journal of Neuroscience.

[65]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[66]  Huaxi Xu,et al.  Trafficking regulation of proteins in Alzheimer’s disease , 2014, Molecular Neurodegeneration.

[67]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[68]  M. Ohno,et al.  Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic mice , 2010, Journal of neurochemistry.

[69]  R. Huganir,et al.  Homeostatic Scaling Requires Group I mGluR Activation Mediated by Homer1a , 2010, Neuron.

[70]  J. Cameron,et al.  Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. , 2003, Cancer research.

[71]  P. Worley,et al.  Corrections to "Pentraxins Coordinate Excitatory Synapse Maturation and Circuit Integration of Parvalbumin Interneurons" [Neuron 85, 1257-1272; March 18, 2015] , 2016 .

[72]  A. Willette,et al.  Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer’s disease spectrum , 2016, Brain, Behavior, and Immunity.

[73]  C. Barnes,et al.  Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  I. T. Draper.  THE ASSESSMENT OF APHASIA AND RELATED DISORDERS , 1973 .

[75]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[76]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[77]  R. Huganir,et al.  Interaction of the N-Terminal Domain of the AMPA Receptor GluR4 Subunit with the Neuronal Pentraxin NP1 Mediates GluR4 Synaptic Recruitment , 2007, Neuron.

[78]  O. Paulsen,et al.  Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro , 1998, Nature.

[79]  L. McEvoy,et al.  Predicting MCI outcome with clinically available MRI and CSF biomarkers , 2011, Neurology.

[80]  R. O’Brien,et al.  Narp and NP1 Form Heterocomplexes that Function in Developmental and Activity-Dependent Synaptic Plasticity , 2003, Neuron.

[81]  A. Kirkwood,et al.  Obligatory Role for the Immediate Early Gene NARP in Critical Period Plasticity , 2013, Neuron.

[82]  Erol Başar,et al.  A review of gamma oscillations in healthy subjects and in cognitive impairment. , 2013, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[83]  Christopher J James,et al.  Distinguishing low frequency oscillations within the 1/f spectral behaviour of electromagnetic brain signals , 2007, Behavioral and Brain Functions.

[84]  M. Meffert,et al.  Dual Regulation of miRNA Biogenesis Generates Target Specificity in Neurotrophin-Induced Protein Synthesis , 2012, Cell.

[85]  H. Vankova.  Mini Mental State , 2010 .

[86]  Isabelle Rouleau,et al.  Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease , 1992, Brain and Cognition.

[87]  Ole Paulsen,et al.  Priming of Hippocampal Population Bursts by Individual Perisomatic-Targeting Interneurons , 2010, The Journal of Neuroscience.

[88]  W. F. Vonderhaar.  A COMPARATIVE STUDY OF PERFORMANCE SCALE IQ'S AND SUBTEST SCORES OF DEAF CHILDREN ON THE WECHSLER INTELLIGENCE SCALE FOR CHILDREN AND THE WECHSLER INTELLIGENCE SCALE FOR CHILDREN-REVISED , 1977 .